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ABSTRACT
Background and Objectives: Left ventricular hypertrophy (LVH) is a well known cardiovascular prognostic predictor. Os-
teoporosis has been suggested to be associated with cardiovascular disease. According to studies of primary hyperparathyroid-
ism, a pathophysiological association between calcium metabolism and LVH has been suggested but is not yet fully under-
stood. This study was performed to investigate the association between bone mineral density (BMD) and left ventricular mass 
index (LVMI) in a general population. Subjects and Methods: Data from 460 subjects among 543 subjects sampled from a 
general population in a rural area in Korea were analyzed. BMD, echocardiography, brachial-ankle pulse wave velocity (ba-
PWV), carotid intima-media thickness (IMT) measurement as well as the measurements of blood pressure, blood chemistry 
and metabolic parameters were analyzed. BMD was measured using the Sahara Clinical Bone Sonometer (Hologic Inc., Mass., 
USA). Results: Age of the subjects was 59.4±12.4 years. Males were 42.2% (n=194). In a simple correlation analysis on female 
subjects, age and waist circumference showed negative correlation, and body mass index (BMI) showed positive correlation 
with BMD. However, only age showed negative correlation with BMD in male subjects. After adjusting baPWV and carotid IMT, 
we found that BMD was an independent determinant of LVMI in female subjects (β=-13.703, p=0.016), but not in male sub-
jects (β=-1.235, p=0.841). Conclusion: BMD is a consistent and independent determining factor of LVMI, BMI and carotid 
IMT in postmenopausal women. (Korean Circ J 2010;40:573-580)
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Introduction
Left ventricular hypertrophy (LVH) and increased left ven-
tricular mass index (LVMI) are well known cardiovascular 
prognostic predictors.
1)2) In patients with stable coronary 
heart disease, increased LVMI is independently associated 
with all-cause mortality and sudden or arrhythmic death, even 
in subjects with normal ejection fraction.
3) Many factors such 
as blood pressure, circulatory volume load as well as age, body 
size and sex can influence left ventricular (LV) mass.
4)5) Cur-
rently, osteoporosis has been suggested as another risk factor 
associated with cardiovascular disease.
6)7) In addition, low 
bone mineral density (BMD) in postmenopausal women is as-
sociated with increase in cardiovascular mortality.
8) In the re-
cent Framingham study, low bone mass showed correlation 
with coronary artery disease in women.
9) According to studies 
in primary hyperparathyroidism, increased parathyroid hor-
mone and serum calcium can affect cardiomyocytes, vascular 
endothelial cells and vascular smooth muscle cells.
10) This co-
uld lead to hypertrophy of cardiomyocytes and vascular en-
dothelial cell dysfunction, finally resulting in cardiac diastol-
ic dysfunction and cardiac hypertrophy. Moreover, the causal 
relationship between low BMD and LVMI in postmenopausal 
women could be explained by hormonal changes, for exam-
ple, decreased osteoprotegrin (OPG) levels in this population.
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Although a pathophysiological association between calcium 
metabolism and LVH has been suggested, few epidemiologic 
studies have been performed. The objective of this study was 
to investigate the association between BMD and LVMI in a ge-
neral population.
 
Subjects and Methods
Study population
A cross sectional analysis was performed on a general popul-
ation who lived in rural area, Korea from 2004 to 2005. A to-
tal of 543 subjects were sampled from the general population 
and informed consents were obtained from 502 subjects at st-
udy entry. Subjects were required to answer a questionnaire 
which included basic demographic, social economic infor-
mation and past medical history. Lifestyle parameters includ-
ing smoking, drinking, daily physical activity and dietary pat-
terns were reviewed. Among these subjects, an echocardiogra-
phy, carotid intima-media thickness (IMT), brachial-ankle 
pulse wave velocity (baPWV) and BMD were performed in 
468 subjects. A complete physical examination including he-
ight, weight, waist circumference, heart rate and blood pres-
sure was done and blood chemistry including fasting blood 
glucose (FBG) and lipid profile were analyzed. In total, 42 
subjects were excluded due to incomplete data (n=34) and 
pre-existing cardiovascular disease (n=8). Subjects with hyper-
tension or under treatment with antihypertensive medications 
(112 subjects, male 49%) and diabetes (34 subjects, male 41%) 
were included in the analysis. Finally, 460 subjects were in-
cluded in the analysis.
Echocardiography
Two-dimensional and guided M-mode echocardiograms 
were performed on each subject by a single cardiologist using 
a commercially available machine (HP SONOS 2500; Hew-
lett Packard, USA) with a 2.5/2.0 MHz transducer. Measure-
ments for M-mode guided calculations of LV mass were taken 
at or just below the tip of the mitral valve with a paper speed 
of 50 mm/sec. The LV internal end-diastolic dimension, end-
systolic dimension (LVID), inter ventricular septal thickness 
(IVST) and posterior wall thickness (PWT) were measured 
on the leading edge, according to the guidelines of the Ameri-
can Society of Echocardiography. LV mass was calculated 
using the following equation: LV mass={1.04×(IVSTd+LVDd+ 
PWTd)
3-LVIDd
3}×0.8+0.6.
12) LVMI was calculated using the 
following equation: LVMI=LV mass/height
2.7.
5)13)
Doppler echocardiographic recordings were performed 
by pulse-wave Doppler with the sample volume at the tips of 
the mitral valve in the apical four-chamber view and recorded 
at a paper speed of 100 mm/sec. Early (E) and late (A) diastolic 
peak velocities and deceleration time were determined, as pre-
viously reported.
14) 
Bone mineral density
BMD was measured by the Sahara Clinical Bone Sonome-
ter (Hologic Inc., Waltham, MA, USA) which is a radiation-
free, waterless, dry system. It consists of two unfocused trans-
ducers mounted coaxially on a motorized caliper. One trans-
ducer acts as transmitter and the other as receiver. The Sahara 
device measures both broadband ultrasound attenuation 
(BUA) and the speed of sound (SOS) at a fixed region of in-
terest in the mid-calcaneus. BUA, expressed in decibel per 
megahertz (dB/MHz), is the slope of attenuation as a function 
of frequency as ultrasound waves pass the heel. SOS, expressed 
in meters per second (m/second), is the transit velocity of a 
high frequency sound wave through the heel. The results are 
combined to provide an estimate of heel BMD in units of 
grams per square centimeter, using the following equation:
15) 
BMD=0.002592×(BUA+SOS)-3.687 g/cm
2
Brachial-ankle pulse wave velocity
BaPWV was measured based on conventional methods with 
the use of automatic waveform analysis (VP-2000; Colin Medi-
cal Technology Co., Komaki, Japan) after resting in the supine 
position for at least 5 minutes following stabilization of the 
heart rate.
16) baPWV between the bilateral brachial arteries and 
the ankle was measured by placing both arms and the ankle in 
a cuff, to which an oscillometric sensor was implanted. The 
mean of the left and right baPWV was used in the analysis.
Carotid intima-media thickness
The bilateral common carotid arteries (CCAs) were meas-
ured using the SA 9900 system (Medison Co. Korea) with a 
7.5-MHz linear transducer. Scanning was performed at the 
far wall of the middle and distal CCAs using a lateral longi-
tudinal projection. The authors decided on the measurement 
protocol according to previously published epidemiologic stu-
dies, and defined IMT at the CCA as the distance between 
the leading edge of lumen-intima interface and the leading 
edge of the media-adventitia interface.
17)18) Five measurements 
were made on each side and the average measurement was 
used as the IMT. To avoid inter-observer variability, all meas-
urements were performed by the same examiner who was un-
aware of subject characteristics. Intra-observer variability was 
already evaluated before including the data in this paper. To 
evaluate intra-observer variability, 20 subjects were random-
ly sampled and measurements were made twice on each sub-
ject. The correlation coefficient at the left bulb, left common ca-
rotid, right bulb and right common carotid area was 0.92, 0.90, 
0.92 and 0.91, respectively.
Statistical analysis
Sex stratified analyses were conducted due to different char-
acteristics. Independent t-test and chi-square test were per-
formed to compare the general characteristics and clinical re-Young-Hyo Lim, et al.   575
sults with sex group. Pearson’s correlation and stepwise mul-
tiple regression analysis were used to identify significant deter-
minants for BMD and LVMI. The criterion for entry into mul-
tiple regression analysis was p<0.05 while the removal criterion 
was p>0.10. A p of less than 0.05 was considered statistically 
significant. Data were analyzed using Statistical Package for 
the Social Sciences (SPSS) 16.0 software (SPSS Inc., Chicago, 
IL, USA).
Results
General characteristics of study subjects
The demographic characteristics of the subjects are sum-
marized in Table 1. The age of the subjects was 59.4±12.4 years. 
42.2% (n=194) were male. There was no statistical difference 
between the gender groups in age, waist circumference, systolic 
blood pressure (SBP) and diastolic blood pressure, pulse pres-
sure and heart rate. However, significant differences in height, 
weight and body mass index (BMI) were noted. Although the 
total cholesterol and low density lipoprotein-cholesterol (LDL-
C) levels were higher in female subjects, these profiles were 
within normal range in both sexes. The proportion of smokers 
was greater in male than in female subjects. 
Clinical characteristics of the subjects
BMD, baPWV, carotid IMT and echocardiographic find-
ings of the subjects are shown in Table 2. BMD, baPWV and 
carotid IMT of all subjects were within the normal range, 0.47 
±0.13 g/cm
2, 1,510.8±271.0 cm/s and 0.63±0.18 mm, respec-
tively. BMD, baPWV, carotid IMT in male subjects were high-
er than that of female subjects (BMD; 0.51±0.11 g/cm
2 vs. 
0.44±0.13 g/cm
2, p<0.001, baPWV; 1,539.3±265.0 cm/s vs. 
1,490.±273.9 cm/s, p=0.05, carotid IMT; 0.65±0.18 mm vs. 
0.61±0.17 mm, p=0.03). The LVMI of study subjects was 47.8 
±11.4 g/m
2.7, and significant difference was not shown be-
tween male and female subjects (47.1±10.7 g/m
2.7 vs. 48.3± 
11.8 g/m
2.7, p=0.26).
Determinants of bone mineral density
Among the clinical parameters, being female (r=-0.288, p< 
0.001), age (r=-0.246, p<0.001), waist circumference (r= 
-0.083, p<0.05), pulse pressure (r=-0.129, p<0.01) and LDL-C 
(r=-0.187, p<0.001) were negatively correlated with BMD. Cur-
rent smokers showed negative correlation with BMD (r= 
-0.140, p<0.001). In male subjects, only age (r=-0.121, p<0.05) 
showed correlation with BMD, whereas in female subjects, 
age (r=-0.356, p<0.001), waist circumference (r=-0.103, p< 
0.05), SBP (r=-0.126, p<0.05), pulse pressure (r=-0.209, p<0.001), 
FBG (r=-0.115, p<0.05) and LDL-C (r=-0.148, p<0.01) sh-
owed negative correlation with the BMD. BMI was positively 
correlated with BMD (r=0.149, p<0.01). In the stepwise mul-
tiple regression analysis, sex (β=-0.312, p<0.001), age (β= 
-0.182, p<0.001), BMI (β=0.382, p<0.001), waist circumfer-
ence (β=-0.342, p<0.01) and LDL-C (β=-0.087, p<0.05) were 
independent determinants of BMD. BMI, waist circumfer-
ence as well as age were determinants of BMD in the female 
Table 1. Clinical characteristics of the population as a whole and divided into groups according to sex
Parameters Total (n=460) Male (n=194) Female (n=266) p
Age (years) 059.4±12.4 059.8±12.2 059.2±12.6 0.570
Height (cm) 157.8±9.00 165.4±6.30 152.2±6.20 <0.001
Weight (kg) 061.3±10.6 065.6±10.2 58.1±9.8 <0.001
WC (cm) 87.9±9.0 87.1±8.1 88.4±9.6 0.120
BMI (kg/m
2) 24.5±3.4 23.9±2.9 25.0±3.6 <0.001
SBP (mmHg) 123.9±15.8 124.4±16.3 1 23.6±15.4 0.590
DBP (mmHg) 80.3±9.3 80.7±9.6 80.0±9.1 0.420
PPr (mmHg) 043.6±11.6 043.6±12.4 043.6±11.1 0.940
HR (bpm) 67.9±9.4 67.1±9.7 68.4±9.1 0.160
Blood chemistry  (mg/dL)
FBG 098.7±27.6 100.2±30.2 097.6±25.5 0.320
TC 186.9±38.0 177.7±36.3 193.7±37.8 <0.001
TG 147.0±87.6 151.3±90.9 143.8±85.1 0.370
HDL-C 049.8±11.8 048.7±12.4 050.5±11.2 0.110
LDL-C 100.4±32.9 091.1±32.3 107.2±31.8 <0.001
Smoking, n (%) None 112 (57.7) 256 (96.2) <0.001
Smoker 082 (42.3) 10 (3.8)
Data are reported as means±SD, p by Chi-square test for smoking status. WC: waist circumference, BMI: body mass index, SBP: systolic blood 
pressure, DBP: diastolic blood pressure, HR: heart rate, FBG: fasting blood glucose, TC: total cholesterol, TG: triglyceride, HDL-C: high density 
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subjects (Table 3). 
The relevance of left ventricular mass index and 
bone mineral density
Separate analyses were conducted for men and women due 
to their different general characteristics. BMD correlated with 
baPWV, carotid IMT and LVMI in female subjects (Table 4) 
(Fig. 1). Five models were used to estimate the relevance of LV-
MI and BMD (Table 5 and 6). The first model adjusted for age, 
current smoking, BMI and SBP (smoking was not adjusted in 
females due to low prevalence of smokers among female sub-
jects) showed that although BMI and SBP were independent 
determinants of LVMI in male subjects, BMD was not an in-
dependent factor. However, in female subjects, BMD was an 
Table 2. Bone mineral density, carotid IMT, baPWV and echocardiographic findings of the population as a whole and divided into groups ac-
cording to sex 
Total (n=460) Male (n=194) Female (n=266) p
BMD (g/cm
2) 000.47±0.13 000.51±0.11 000.44±0.13 <0.001
baPWV (cm/s) 1.510.8±271.0 1,539.3±265.0 1,490.0±273.9  0.050
Carotid IMT (mm) 000.63±0.18 000.65±0.18 000.61±0.17 0.030
Echocardiography 
IVSd (mm) 0010.3±1.40 010.7±1.4  010.0±1.4  <0.001
LVIDd (mm) 0048.3±4.50 050.3±4.1  046.8±4.2  <0.001
LVPWTd (mm) 0008.8±1.20 009.1±1.1  008.7±1.3  <0.001
IVSs (mm) 0014.0±1.90 014.6±1.8  013.5±1.8  <0.001
LVIDs (mm) 0029.2±4.30 031.1±4.0  027.8±3.9  <0.001
LVPWT,s (mm) 0013.3±1.70 013.7±1.7  013.0±1.6  <0.001
AoD (mm) 0030.6±3.10 032.2±2.8  029.5±2.9  <0.001
LAD (mm) 0032.3±4.20 033.3±4.2  031.6±4.1  <0.001
E (cm/s) 0067.8±17.6  0065.7±18.2  0069.4±17.0  0.030
A (cm/s) 0074.3±16.1  0070.8±15.5  0076.9±16.0  <0.001
DT (ms) 0201.1±35.2  0203.9±38.2  0199.0±32.8  0.150
IVRT (ms) 0075.8±11.9  0076.3±12.3  0075.5±11.6  0.470
LVMI (g/m
2.7) 0047.8±11.4 0047.1±10.7 0048.3±11.8 0.260
Data are reported as mean±SD. BMD: bone mineral density, IMT: intima-media thickness, baPWV: brachial ankle pulse wave velocity, IVSds: 
interventricular septal thickness diastole, systole, LVIDds: left ventricular internal dimension diastole, systole, LVPWTd,s: left ventricular pos-
terior wall thickness diastole, systole, AoD: aortic diameter, LAD: left atrial dimension, E: early diastolic peak velocity, A: late diastolic peak ve-
locity, DT: deceleration time, IVRT: isovolumic relaxation time, LVMI: left ventricular mass index
Table 3. Pearson’s correlation coefficients between BMD and clinical parameters, and clinical predictors of BMD in stepwise multiple linear re-
gression analysis
Parameters
BMD
Total (n=460) Male (n=194) Female (n=266)
r β  r β r β 
Sex -0.288* -0.312*
Age -0.246* -0.182* -0.121‡ -0.092 -0.356* -0.248*
BMI -0.067 -0.382* -0.072 -0.181 -0.149‡ -0.428*
WC -0.083‡ -0.342* -0.003 -0.186 -0.103‡ -0.376*
SBP -0.051 -0.025 -0.034 -0.001 -0.126‡ -0.036
DBP -0.075 -0.022 -0.106 -0.078 -0.040 -0.021
PPr -0.129† -0.050 -0.037 -0.016 -0.209* -0.104
FBG -0.040 -0.021 -0.018 -0.005 -0.114‡ -0.043
HDL -0.041 -0.017 -0.034 -0.042 -0.011 -0.010
LDL -0.187* -0.083‡ -0.093 -0.084 -0.148‡ -0.062
Adjusted R
2 (%) 19.5 20.3 20.1
*p<0.001, †p<0.01, ‡p<0.05. BMD: bone mineral density, BMI: body mass index, WC: waist circumference, SBP: systolic blood pressure, DBP: dia-
stolic blood pressure, PPr: pulse pressure, FBG: fasting blood glucose, HDL: high density lipoprotein, LDL: low density lipoproteinYoung-Hyo Lim, et al.   577
independent determinant of LVMI (β=-22.123, p<0.0001). In 
model 2, additional variables such as abdominal circumfer-
ence, fasting glucose and lipid profile were included. In model 
2, although BMD did not have an effect in males, BMD (β= 
-18.659, p=0.01) was an independent determinant for LVMI 
along with BMI and SBP in female subjects. In models 3 and 
4, after adjusting the clinical parameters in model 2, the in-
dividual effects of arterial stiffness parameters such as baPWV 
and carotid IMT on LVMI were evaluated. Although baPWV 
was not related to LVMI, carotid IMT showed an independent 
effect on LVMI in both male and female subjects (β=10.262, 
p<0.018, β=21.456, p<0.0001, respectively). Finally, in model 
5, the relationship between BMD and LVMI was evaluated, 
after adjusting not only previous clinical parameters noted ab-
ove but also baPWV and carotid IMT. BMD did not have an ef-
fect in male subjects (β=-1.235, p=0.841). However, it was a ne-
gative determinant for LVMI in female subjects, along with 
BMI and carotid IMT (β=-13.703, p=0.016). 
Discussion
The main finding of the study is that BMD is a consistent 
determinant of LVMI in postmenopausal female subjects. Fur-
thermore, BMD is independent of BMI, blood pressure, che-
mistry profiles, and the parameters of arterial stiffness such as 
carotid IMT and baPWV in determining LVMI. This finding 
suggests that the pathophysiological concept derived from 
primary hyperparathyroidism can be applied to the relation-
ship between BMD and LVMI in postmenopausal female pa-
tients. In primary hyperparathyroidism, increased serum cal-
cium and osteoporosis could lead to hypertrophy of the car-
diomyocytes and vascular endothelial cell dysfunction, finally 
resulting in cardiac diastolic dysfunction and cardiac hyper-
trophy.
10) It is well known that LVMI is determined not only by 
hemodynamic factors, such as systolic blood pressure and ar-
terial stiffness, but also by non-hemodynamic factors such as 
obesity. BMD is a non-hemodynamic factor and the interpre-
tation of the relationship with LVMI could be confounded by 
many factors. For optimal adjustment of hemodynamic fac-
tors, we included baPWV and carotid IMT, which are stiffness 
parameters for peripheral or central arteries, respectively, in 
the multiple regression model. This was important because 
arterial stiffness may have clinical relevance in the age (59.4 
±12.4 years) of this study population. 
In this study, BMD as a non-hemodynamic factor that sh-
owed correlation with LVMI in female subjects only (Table 4) 
(Fig. 1). According to the stepwise multiple linear regression 
analysis compensated with various clinical parameters along 
with baPWV and carotid IMT, BMD was a consistent and 
independent determinant for LVMI in female subjects (Table 
6). These findings are comparable to that in previous studies, 
which reported that non-hemodynamic factors were more 
important in female subjects.
19)20) Although more study is 
needed to clarify the causal relationship between low BMD 
and LVMI in postmenopausal women, hormonal changes in 
this population may be a possibility. For example, a change 
in hormones, including OPG in postmenopausal women, is 
involved in LV hypertrophy and vascular calcification as well 
as reduction in bone mass.
11)21)22) 
The relationship between BMD and baPWV or carotid IMT 
was also more definite in female subjects (Fig. 1). BMD was a 
greater determinant in cardiovascular change in female sub-
jects, compared to male subjects. The difference between sex-
es may be explained by the following clinical characteristics: 
BMI was higher in female subjects (25.0±3.6 vs. 23.9±2.9, p< 
0.001), LDL was also higher (107.2±31.8 vs. 91.1±32.3, p< 
0.001) and BMD was lower compared to male subjects (0.44± 
0.13 g/cm
2 vs. 0.51±0.11 g/cm
2, p<0.001). Generally, in sub-
jects of this age group (59.4±12.4 years), BMD is lower in fe-
male compared to male subjects, and this could be due to dif-
ferences in hormonal changes at this age.
According to the findings of our study, low BMD has harm-
ful effects on the vascular structure and/or stiffness. Subse-
quently, increased arterial stiffness may contribute to LV hy-
pertrophy. But considering that the effects of low BMD on 
LVH are independent, even after adjusting baPWV and ca-
rotid IMT, suggestive that low BMD could have direct influ-
ence on LV hypertrophy. 
These results attribute to previous reports on the possibility 
of osteoporosis as a risk factor for cardiovascular disease.
6)7) 
Moreover, osteopenia or osteoporosis and atherosclerotic vas-
cular disease (coronary artery disease, ischemic stroke, or pe-
ripheral arterial disease) are common conditions in postme-
nopausal women.
23)24) Osteoporosis and vascular calcification 
have been largely attributed to the aging process. However, 
recent studies have shown that arterial calcification is a highly 
Table 4. Pearson’s correlation coefficients between BMD and LVMI, baPWV and carotid IMT in subjects
Variables
BMD
Total (n=460) Male (n=194) Female (n=266)
r p r p r  p
baPWV -0.195 <0.001 -0.094 0.191 -0.318 <0.001
Carotid IMT -0.201 <0.001 -0.061 0.400 -0.373 <0.001
LVMI (g/m
2.7) -0.163 <0.001 -0.007 0.918 -0.243 <0.001
BMD: bone mineral density, baPWV: brachial ankle pulse wave velocity, IMT: intima-media thickness, LVMI: left ventricular mass index578  BMD and LV Mass Index 
regulated process, with intriguing similarities to bone turn-
over that may be age-independent.
25)26) In a previous study, 
low BMD was associated with increased risk of ischemic st-
roke, and was found to be a possible predictor for first stroke 
among older women.
27)28) In another study, osteoporosis was 
linked to peripheral arterial disease independent of age and 
gender,
29) and low BMD correlated with ankle-brachial in-
dexes.
30) In our study, we also found that in postmenopausal 
women, low BMD contributes to central and peripheral vas-
cular stiffness, which are reflected by carotid IMT and baP-
Fig. 1. Correlation between bone mineral density (BMD) and brachial ankle pulse wave velocity (baPWV), carotid intima-media thickness 
(IMT) and left ventricular mass index (LVMI).
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WV, respectively. Moreover, we found that decrease in BMD 
has a weak, but definite contribution to increase in LVMI, 
leading to LVH even before osteoporosis sets place in post-
menopausal women. From the standpoint of clinical relevance, 
the consistent relationship with relatively low strength between 
BMD, cardiac and vascular surrogates suggests that more evi-
dence is needed for bone mineral metabolism to be general-
ly accepted as a clinically valuable mechanism for cardiac and 
vascular health.
This study was a cross sectional analysis and BMD was meas-
ured by bone sonometer in the calcaneal bone, not the lum-
bar spine or femur neck, which limit result interpretation. 
For a hard endpoint on this subject, a large scale prospective 
study is warranted. However, this study gives us insights into 
the relationship between BMD and various cardiovascular 
parameters in postmenopausal female subjects. We found that 
BMD serves as a consistent and independent factor in deter-
mining LVMI, baPWV and carotid IMT in postmenopausal 
female subjects. 
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Table 5. Multivariate analysis of between LVMI and clinical parameters in male subjects
Model 1 Model 2 Model 3 Model 4 Model 5
β p β p β p β p β p
Age -0.145  0.0180  -0.091  0.1570  -0.110  0.0920 -0.045  0.4920 -0.064  0.3390
Smoking -1.101  0.4540 -0.859  0.5620 -0.950  0.5200 -0.951  0.5140 -1.038  0.4770
BMI -1.012  <0.0001 -1.188  0.0190 -1.103  0.0300 -1.122  0.0240 -1.030  0.0410
WC -0.015  0.9300 -0.038  0.8290 -0.012  0.9460 -0.034  0.8460
SBP -0.194  <0.0001 -0.319  <0.0001 -0.365  <0.0001 -0.295  <0.0001 -0.347  <0.0001
DBP -0.339  0.0020 -0.362  0.0010 -0.292  0.0060 -0.314  0.0040
FBG -0.009  0.7170 -0.016  0.5120 -0.004  0.8770 -0.012  0.6160
HDL-C -0.019  0.7590 -0.023  0.6990 -0.031  0.6090 -0.036  0.5470
LDL-C -0.012  0.6050 -0.012  0.6040 -0.029  0.2170 -0.030  0.1980
baPWV -0.004  0.2200 -0.005  0.1490
cIMT 10.262  0.0180 10.766 0.0130
BMD -1.428  0.8200  -0.362  0.9540 -1.235  0.8410
Adjusted R
2 (%) 18.9  23.4  24.0  25.7  26.6 
LVMI: left ventricular mass index, BMI: body mass index, WC: waist circumference, SBP: systolic blood pressure, DBP: diastolic blood pressure, 
FBG: fasting blood glucose, HDL-C: high density lipoprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol, baPWV: brachial ankle 
pulse wave velocity, cIMT: carotid intima-media thickness, BMD: bone mineral density
Table 6. Multivariate analysis between LVMI and the clinical parameters in female subjects
Model 1 Model 2 Model 3 Model 4 Model 5
β p β p β p β p β p
Age 0.097  0.0820 -0.073  0.204  -0.109  0.060  -0.045  0.423 -0.020 0.723
BMI 1.066  <0.0001 -0.806  0.014  -0.627  0.068  -0.783  0.012 -0.949 0.005
WC -0.154  0.205  -0.216  0.085  -0.140  0.231 -0.088 0.468
SBP 0.088  0.0540 -0.149  0.018  -0.145  0.041  -0.112  0.071 -0.105  0.122
DBP -0.181  0.095  -0.204  0.066  -0.162  0.127 -0.148  0.160
FBG -0.008  0.750  -0.006  0.817  -0.011  0.655 -0.013  0.604
HDL-C -0.026  0.661  -0.026  0.669  -0.017  0.764 -0.018  0.748
LDL-C -0.022  0.309  -0.027  0.229  -0.006  0.781 -0.005  0.823
baPWV -0.003  0.421  -0.000  0.913
cIMT 21.456  <0.0001 -19.392  <0.0001
BMD -22.123  <0.0001 -18.659  0.001  -13.703  0.016
Adjusted R
2 (%) 20.9  23.0  26.9  28.5 
LVMI: left ventricular mass index, BMI: body mass index, WC: waist circumference, SBP: systolic blood pressure, DBP: diastolic blood pressure, 
FBG: fasting blood glucose, HDL-C: high density lipoprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol, baPWV: brachial ankle 
pulse wave velocity, cIMT: carotid intima-media thickness, BMD: bone mineral density580  BMD and LV Mass Index 
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